Effectiveness of Craniosacral Therapy in Cervicogenic Headache
Keerthi Rao, Subhash Khatri
CONTEXT: Headache is a common phenomenon experienced by everyone at some point in their lives. Hence, it is not surprising that the global estimate of headache sufferers is around 46% and the prevalence of cervicogenic headache (CGH) is 2.5 to 4.1% among all headache types. Craniosacral therapy (CST) is a light touch modality which is fairly safe, noninvasive, and nonpharmacological mode of treatment that can cure a wide array of musculoskeletal and neurological conditions, including headache, but which has limited evidence of effectiveness in literature especially in CGH. MATERIALS AND METHODS: Selection criteria for inclusion in the study were subjects of both gender, age 18 and above, and meeting the CGH International Study Group diagnostic criteria for CGH. All subjects were treated three times a week on alternate days for 3 weeks. RESULTS: Ninety four individuals were screened for eligibility, of which 49 met the selection criteria for the study. Headacherelated disability was present 3.4 Â± 4.1 days during the 3-week period. The average of the HIT-6 score pretreatment was 67.6 Â± 7.8 points and posttreatment was 42.7 Â± 3.6. The correlation analysis of the frequency of headache attacks and duration of disability according to the headache diary significantly correlated with the severity of headache-related disability at each attack. CONCLUSION: Craniosacral therapy is an effective treatment strategy for patients of CGH as measured on HIT-6 during a 3-week treatment program.
Cervicogenic headache, Craniosacral therapy, Headache diary, Headache impact test-6.